🟠 Moderate Evidence
A population-based analysis of Argentina’s National Registry of Congenital Heart Diseases has revealed stark geographic disparities in both the prevalence of congenital heart defects (CHD) and the timing of diagnosis across provinces. Published in PLOS Global Public Health, the study examined 2,473,720 live births between 2014 and 2019 and found that provincial prevalence rates for congenital heart defects ranged from 34.9 to 212.2 per 10,000 live births—a sixfold variation that likely reflects differences in detection infrastructure rather than true disease burden.
Key takeaways
- National prevalence of congenital heart defects was 65.3 per 10,000 live births, with critical cases occurring in 15.0 per 10,000 births (2014–2019 data, Argentina’s National Registry)
- Provincial prevalence varied sixfold (34.9–212.2 per 10,000), suggesting unequal access to early detection and diagnostic capacity across regions
- Median age at diagnosis was 75 days for all CHD cases and 29 days for critical cases, but wide provincial variation indicates inconsistent screening protocols
- Early detection and equitable access to specialized care remain critical gaps in reducing CHD-related mortality in Argentina and similar middle-income settings
Study at a Glance
| Source | PLOS Global Public Health |
| Study type | Cross-sectional, population-based registry analysis |
| Sample size | 2,473,720 live births; 16,150 CHD cases identified |
| Population | Newborns covered by Argentina’s public health system (2014–2019) |
| Country | Argentina |
Provincial Variability in Congenital Heart Defect Prevalence, Argentina 2014–2019
Prevalence per 10,000 live births across five selected provinces; national average 65.3 per 10,000
Source: Vita et al., PLOS Global Public Health, 2024 | Analysis of Argentina’s National Registry of Congenital Heart Diseases
Sixfold variation in detection rates signals unequal diagnostic capacity
The most striking finding from the analysis by María Clara Vita and colleagues was the sixfold difference in provincial prevalence rates. While some variation in disease prevalence between regions is expected, researchers note that the magnitude of this disparity far exceeds what biological factors alone would explain. The highest-reporting province detected 212.2 cases per 10,000 live births, while the lowest reported only 34.9 per 10,000—a gap that almost certainly reflects differences in screening technology, clinician awareness, and referral pathways rather than true underlying disease burden.
This variation mirrors patterns observed in European congenital heart disease surveillance studies, where regions with established neonatal screening programs consistently identify higher prevalence rates than those without standardized detection protocols. The implication is sobering: many Argentine newborns with congenital heart defects—particularly in lower-detection provinces—may go undiagnosed during the critical early window when intervention saves lives.
Critical cases detected at median 29 days, but timing varies widely by region
For critical congenital heart defects—those requiring surgical or interventional management within the first days or weeks of life—the national median age at diagnosis was 29 days, according to the registry data. However, provincial medians showed substantial variation, raising questions about whether all families have equal access to the specialized echocardiography and cardiology services needed for timely diagnosis. Studies on newborn screening for critical congenital heart disease have demonstrated that pulse oximetry screening can detect many of these conditions before discharge from maternity care—typically within 24–48 hours—yet Argentina’s median of 29 days suggests such protocols may not be universally implemented.
For all congenital heart defects combined, the national median age at notification was 75 days. This represents a substantial delay from birth, during which children with undetected moderate-to-severe lesions may develop complications including poor feeding, respiratory distress, and reduced growth. The provincial variation in timing of diagnosis points to a fragmented healthcare system where the province of birth determines not only whether a child is detected, but also how quickly they receive a diagnosis.
Critical infrastructure and equity gaps must be addressed
Argentina’s public health system covers the majority of births analyzed in this study, yet the data reveal marked geographic inequity in early detection capacity. Previous research in Latin American congenital heart disease epidemiology has identified similar disparities linked to unequal distribution of cardiac imaging equipment, specialized pediatric cardiologists, and maternal-fetal medicine expertise. Addressing these gaps requires sustained investment in three key areas: (1) provincial capacity-building for neonatal screening using accessible technologies such as pulse oximetry; (2) telemedicine links to centralized pediatric cardiology services in provinces lacking on-site specialists; and (3) systematic training of primary care physicians and midwives to recognize early signs of congenital heart disease.
The researchers emphasize that their findings should serve as a roadmap for targeted health system strengthening. Provinces with the lowest detection rates likely harbor a hidden burden of undiagnosed congenital heart disease, and linking birth cohorts from low-detection provinces to specialized care networks could improve outcomes. Early diagnosis not only prevents emergency presentations and mortality but also reduces the long-term burden of complications on families and healthcare costs.
Provincial congenital heart defect prevalence ranged from 34.9 to 212.2 per 10,000 live births—a sixfold variation suggesting that many cases remain undetected in lower-capacity regions despite affecting approximately 1 in 150–300 newborns in Argentina.
— María Clara Vita and colleagues, National Registry of Congenital Heart Diseases Analysis (PLOS Global Public Health, 2024)
What this means
Frequently asked questions
Why is early detection of congenital heart disease so important?
Early detection allows treatment before critical complications develop. Newborns with undetected congenital heart defects may develop shock, respiratory failure, or organ damage within days. Studies show that early detection dramatically improves survival and long-term cardiac function, particularly for critical lesions requiring surgery.
What explains the provincial variation in prevalence rates?
The sixfold variation almost certainly reflects differences in diagnostic capacity rather than true disease burden. Provinces with higher detection rates typically have better access to echocardiography, trained pediatric cardiologists, and systematic newborn screening programs. Lower rates suggest undetected cases rather than lower disease occurrence.
Can pulse oximetry screening replace echocardiography for detecting congenital heart disease?
Pulse oximetry is an effective initial screening tool for critical congenital heart defects and can be performed at bedside within 24 hours of birth, but it does not detect all congenital heart defects. Echocardiography remains the gold standard diagnostic test and is required to characterize the lesion and guide treatment decisions.
As Argentina continues strengthening its perinatal healthcare infrastructure, these registry findings underscore the urgency of closing the detection gap. The sixfold provincial variation is not inevitable—it reflects policy and resource choices. With targeted investment in screening capacity and specialist training, Argentina can ensure that every newborn with a congenital heart defect receives timely diagnosis, regardless of where they are born. This is both a clinical imperative and a matter of healthcare equity.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
